Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

NCT01093963 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Enrollment goals not met

Conditions

Bipolar Depression

Interventions

DRUG: Lisdexamfetamine
DRUG: Placebo

Sponsor

Lindner Center of HOPE

Collaborators

[object Object]
[object Object]